Literature DB >> 20512988

Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.

Wing-Kin Syn1, Ye Htun Oo, Thiago A Pereira, Gamze F Karaca, Youngmi Jung, Alessia Omenetti, Rafal P Witek, Steve S Choi, Cynthia D Guy, Caitlin M Fearing, Vanessa Teaberry, Fausto E L Pereira, David H Adams, Anna Mae Diehl.   

Abstract

UNLABELLED: Liver inflammation is greater in nonalcoholic steatohepatitis (NASH) than steatosis, suggesting that immune responses contribute to nonalcoholic fatty liver disease (NAFLD) progression. Livers normally contain many natural killer T (NKT) cells that produce factors that modulate inflammatory and fibrogenic responses. Such cells are relatively depleted in steatosis, but their status in more advanced NAFLD is uncertain. We hypothesized that NKT cells accumulate and promote fibrosis progression in NASH. We aimed to determine if livers become enriched with NKT cells during NASH-related fibrosis; identify responsible mechanisms; and assess if NKT cells stimulate fibrogenesis. NKT cells were analyzed in wildtype mice and Patched-deficient (Ptc(+/-)) mice with an overly active Hedgehog (Hh) pathway, before and after feeding methionine choline-deficient (MCD) diets to induce NASH-related fibrosis. Effects of NKT cell-derived factors on hepatic stellate cells (HSC) were examined and fibrogenesis was evaluated in CD1d-deficient mice that lack NKT cells. NKT cells were quantified in human cirrhotic and nondiseased livers. During NASH-related fibrogenesis in wildtype mice, Hh pathway activation occurred, leading to induction of factors that promoted NKT cell recruitment, retention, and viability, plus liver enrichment with NKT cells. Ptc(+/-) mice accumulated more NKT cells and developed worse liver fibrosis; CD1d-deficient mice that lack NKT cells were protected from fibrosis. NKT cell-conditioned medium stimulated HSC to become myofibroblastic. Liver explants were 2-fold enriched with NKT cells in patients with non-NASH cirrhosis, and 4-fold enriched in patients with NASH cirrhosis.
CONCLUSION: Hh pathway activation leads to hepatic enrichment with NKT cells that contribute to fibrosis progression in NASH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512988      PMCID: PMC2920131          DOI: 10.1002/hep.23599

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

Review 1.  The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy.

Authors:  Karl O A Yu; Steven A Porcelli
Journal:  Immunol Lett       Date:  2005-08-15       Impact factor: 3.685

Review 2.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

3.  Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model.

Authors:  Takeshi Shimamura; Toshio Fujisawa; Syed R Husain; Mitomu Kioi; Atsushi Nakajima; Raj K Puri
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

Authors:  Alessia Omenetti; Alessandro Porrello; Youngmi Jung; Liu Yang; Yury Popov; Steve S Choi; Rafal P Witek; Gianfranco Alpini; Juliet Venter; Hendrika M Vandongen; Wing-Kin Syn; Gianluca Svegliati Baroni; Antonio Benedetti; Detlef Schuppan; Anna Mae Diehl
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

5.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

6.  Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

Authors:  Xiong Ma; Jing Hua; Zhiping Li
Journal:  J Hepatol       Date:  2008-06-30       Impact factor: 25.083

Review 7.  The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer.

Authors:  Alessia Omenetti; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-24       Impact factor: 4.052

8.  Methods for detection, isolation and culture of mouse and human invariant NKT cells.

Authors:  Hiroshi Watarai; Ryusuke Nakagawa; Miyuki Omori-Miyake; Nyambayar Dashtsoodol; Masaru Taniguchi
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 9.  Hepatic NKT cells: friend or foe?

Authors:  Mark G Swain
Journal:  Clin Sci (Lond)       Date:  2008-04       Impact factor: 6.124

10.  Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.

Authors:  Joanne E Croudace; Stuart M Curbishley; Manuela Mura; Carrie R Willcox; Petr A Illarionov; Gurdyal S Besra; David H Adams; David A Lammas
Journal:  BMC Immunol       Date:  2008-12-03       Impact factor: 3.615

View more
  126 in total

1.  HLA DQB1 alleles are related with nonalcoholic fatty liver disease.

Authors:  Levent Doganay; Seyma Katrinli; Yasar Colak; Ebubekir Senates; Ebru Zemheri; Oguzhan Ozturk; Feruze Yilmaz Enc; Ilyas Tuncer; Gizem Dinler Doganay
Journal:  Mol Biol Rep       Date:  2014-08-26       Impact factor: 2.316

2.  Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis.

Authors:  Miroslaw Kornek; Michael Lynch; Shruti H Mehta; Michelle Lai; Mark Exley; Nezam H Afdhal; Detlef Schuppan
Journal:  Gastroenterology       Date:  2012-04-24       Impact factor: 22.682

Review 3.  Roles of liver innate immune cells in nonalcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Wei An
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 4.  Hedgehog signaling in the liver.

Authors:  Alessia Omenetti; Steve Choi; Gregory Michelotti; Anna Mae Diehl
Journal:  J Hepatol       Date:  2010-10-14       Impact factor: 25.083

Review 5.  NKT cells in liver diseases.

Authors:  Shasha Zhu; Huimin Zhang; Li Bai
Journal:  Front Med       Date:  2018-04-06       Impact factor: 4.592

Review 6.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

7.  Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.

Authors:  David J Orlicky; Andrew E Libby; Elise S Bales; Rachel H McMahan; Jenifer Monks; Francisco G La Rosa; James L McManaman
Journal:  J Physiol       Date:  2019-01-02       Impact factor: 5.182

Review 8.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

Review 9.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

Review 10.  Innate immune activation in obesity.

Authors:  Carey N Lumeng
Journal:  Mol Aspects Med       Date:  2012-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.